Intercept Pharmaceuticals Statistics

Total Valuation

Market Cap	n/a
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	+0.15%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	2.18
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.22, with a Debt / Equity ratio of 3.12.

Current Ratio	4.22
Quick Ratio	3.92
Debt / Equity	3.12
Debt / EBITDA	n/a
Debt / FCF	-3.56
Interest Coverage	-5.39

Financial Efficiency

Return on equity (ROE) is -64.02% and return on invested capital (ROIC) is -9.27%.

Return on Equity (ROE)	-64.02%
Return on Assets (ROA)	-7.23%
Return on Invested Capital (ROIC)	-9.27%
Return on Capital Employed (ROCE)	-18.22%
Revenue Per Employee	$931,625
Profits Per Employee	-$180,680
Employee Count	341
Asset Turnover	0.67
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +24.02% in the last 52 weeks. The beta is 0.88, so ICPT's price volatility has been lower than the market average.

Beta (5Y)	0.88
52-Week Price Change	+24.02%
50-Day Moving Average	15.98
200-Day Moving Average	14.74
Relative Strength Index (RSI)	75.79
Average Volume (20 Days)	1,948,637

Short Selling Information

The latest short interest is 10.19 million, so 24.37% of the outstanding shares have been sold short.

Short Interest	10.19M
Short Previous Month	9.43M
Short % of Shares Out	24.37%
Short % of Float	27.77%
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ICPT had revenue of $317.68 million and -$61.61 million in losses. Loss per share was -$1.48.

Revenue	317.68M
Gross Profit	317.05M
Operating Income	-55.10M
Pretax Income	-57.47M
Net Income	-61.61M
EBITDA	-54.72M
EBIT	-55.10M
Loss Per Share	-$1.48

Full Income Statement

Balance Sheet

The company has $322.71 million in cash and $223.86 million in debt, giving a net cash position of $98.86 million.

Cash & Cash Equivalents	322.71M
Total Debt	223.86M
Net Cash	98.86M
Net Cash Per Share	n/a
Equity (Book Value)	71.85M
Book Value Per Share	1.72
Working Capital	292.60M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$63.02 million and capital expenditures $186,000, giving a free cash flow of -$62.83 million.

Operating Cash Flow	-63.02M
Capital Expenditures	186,000
Free Cash Flow	-62.83M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 99.80%, with operating and profit margins of -17.34% and -19.39%.

Gross Margin	99.80%
Operating Margin	-17.34%
Pretax Margin	-18.09%
Profit Margin	-19.39%
EBITDA Margin	-17.22%
EBIT Margin	-17.34%
FCF Margin	n/a

Dividends & Yields

ICPT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-35.22%
Shareholder Yield	-35.22%
Earnings Yield	n/a
FCF Yield	n/a

Analyst Forecast

The average price target for ICPT is $22.50, which is 18.42% higher than the current price. The consensus rating is "Hold".

Price Target	$22.50
Price Target Difference	18.42%
Analyst Consensus	Hold
Analyst Count	10
Revenue Growth Forecast (5Y)	4.42%
EPS Growth Forecast (5Y)	-24.16%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ICPT has an Altman Z-Score of -5.42 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.42
Piotroski F-Score	3